Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies - Smitherman, Todd A.; Tietjen, Gretchen E.; Schuh, Kory; Skljarevski, Vladimir; Lipsius, Sarah; D’Souza, Deborah N.; Pearlman, Eric M. (Headache, 2020)
Keywords: Anxiety; comorbid; Comorbidity; Confidence intervals; depression; Double-blind studies; Evaluation; galcanezumab; Headache; Health services; Impairment; Medical history; Mental depression; Migraine; Monoclonal antibodies; Patients; Prevention; Research Submission; Research Submissions; Statistical analysis; Subgroups; comorbid; anxiety; migraine; depression; galcanezumab; prevention